Kestra Medical Technologies (KMTS) Gross Margin (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Gross Margin data on file, last reported at 52.57% in Q1 2026.

• Gross Margin for Q1 2026 came in at 52.57%, up 918.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 48.75% (up 1460.0% YoY), and the FY2025 annual result was 40.47%, up 3917.0% from the prior year.
• Gross Margin rose to 52.57% in Q1 2026 per KMTS's latest filing, from 50.63% in the prior quarter.
• Over five years, Gross Margin peaked at 52.57% in Q1 2026 and troughed at 10.63% in Q1 2024.
• A 3-year average of 37.06% and a median of 43.39% in 2025 frame the typical range for Gross Margin.
• The sharpest annual moves came in 2025 and 2026: Gross Margin jumped 3275 bps in 2025, then soared 918 bps in 2026.
• A 3-year view of Gross Margin shows it stood at 39.63% in 2024, then grew by 28 bps to 50.63% in 2025, then climbed by 4 bps to 52.57% in 2026.
• Business Quant data shows KMTS's Gross Margin at 52.57% in Q1 2026, 50.63% in Q4 2025, and 45.69% in Q3 2025.